(CBDRA60) to Prevent or Reduce Symptoms of COVID-19 and Prevention of Post-Acute Sequelae of SARS-CoV-2 Infection PASC
Clinical trial NCT04777981 · UNKNOWN
Trial details
- NCT number
- NCT04777981
- Sponsor
- Anewsha Therapeutics Inc.
- Status
- UNKNOWN
- Phase
- Not Applicable
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-01
- Primary completion
- 2022-12-05
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.